Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Viridian Therapeutics, Inc. (VRDN) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Viridian Therapeutics, Inc. (VRDN) on November 6, 2026 is 28.71 $, +0.56 % on the day. Over 52 weeks the stock traded between 13.18 $ and 34.29 $; the price now sits 74 % of the way up that range. Over the past year the price changed by +7.07 %. Market capitalization is 3.25 billion $, rank 54 among 381 stocks of the same industry with a known capitalization.
Viridian Therapeutics, Inc. trades on Nasdaq under the ticker VRDN. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks VRDN has traded between 13.18 $ and 34.29 $. As of 6 November 2026 the price stood 57.41% of the way from the 52-week low to the high.
Over one year VRDN shares rose 7.07%; over six months they rose 79.94%. Volatility over 90 days is 50.25%. Dividends are not included: this is price change only, as of 6 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 45.7, above the sector median of 3.6. Price to book is 4.9, above the sector median of 2.3. Calculated from reports for the period ending 30 June 2026.
Viridian Therapeutics, Inc. reported revenue of 71M $ and a net loss of 387M $ over the last four quarters. Net margin is −544.06%. Revenue changed by +23,220.33% year over year. Market capitalisation is 3.3B $.
VRDN has a return on equity of −58.45%, below the sector median of −40.58%. Return on assets is −35.27%, below the sector median of −30.08%. Operating margin is −569.68%, below the sector median of −20.96%.